LSD1/CoREST is an allosteric nanoscale clamp regulated by H3-histone-tail molecular recognition

The complex of lysine-specific demethylase-1 (LSD1/KDM1A) with its corepressor protein CoREST is an exceptionally relevant target for epigenetic drugs. Here, we provide insight into the local and global changes of LSD1/CoREST conformational dynamics that occur upon H3 binding on the basis of a total cumulative time of one microsecond molecular dynamics simulation. The LSD1/CoREST complex functions as an allosteric nanoscale-binding clamp, which is regulated by substrate binding. In the unbound state, LSD1/CoREST reversibly visits clamp states that are more open or significantly more closed compared with the available X-ray crystal structures. The Lys triad of residues Lys355, Lys357, and Lys359 gates the entrance of the H3 pocket. H3 binding shifts the pocket breathing dynamics toward open, higher-volume states while reducing the overall flexibility of the LSD1/CoREST nanoscale clamp. We show that the H3 pocket is an allosteric site for the regulation of the rotation of the amino oxidase domain with respect to the Tower domain. The allosteric mechanism relies on the specific reduction of nanoscale domain rotation upon local H3-tail binding. Instead, clamp opening/closing motions that do not involve domain rotation only reduce in amplitude yet are dominant in the bound state. Overall, our data suggest that the H3 binding pocket is a central target site to (i) switch off LSD1 amino oxidase activity, thus H3-tail demethylation; (ii) block the competitive binding of transcription factors; and (iii) prevent chromatin anchoring to LSD1/CoREST. This study underscores the importance of receptor flexibility for future epigenetic drug discovery.

[1]  A. Mclachlan Gene duplications in the structural evolution of chymotrypsin. , 1979, Journal of molecular biology.

[2]  H. Berendsen,et al.  Interaction Models for Water in Relation to Protein Hydration , 1981 .

[3]  J. Åqvist,et al.  Ion-water interaction potentials derived from free energy perturbation simulations , 1990 .

[4]  García,et al.  Large-amplitude nonlinear motions in proteins. , 1992, Physical review letters.

[5]  H. Berendsen,et al.  Essential dynamics of proteins , 1993, Proteins.

[6]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[7]  Chris Oostenbrink,et al.  A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..

[8]  Yang Shi,et al.  Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1 , 2004, Cell.

[9]  F. Forneris,et al.  Histone demethylation catalysed by LSD1 is a flavin‐dependent oxidative process , 2005, FEBS letters.

[10]  F. Forneris,et al.  Human Histone Demethylase LSD1 Reads the Histone Code* , 2005, Journal of Biological Chemistry.

[11]  Leo S. D. Caves,et al.  Bio3d: An R Package , 2022 .

[12]  André Hoelz,et al.  Crystal structure and mechanism of human lysine-specific demethylase-1 , 2006, Nature Structural &Molecular Biology.

[13]  R. Schüle,et al.  Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. , 2006, Cancer research.

[14]  Z. Otwinowski,et al.  Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. , 2006, Molecular cell.

[15]  Yong Chen,et al.  Crystal structure of human histone lysine-specific demethylase 1 (LSD1) , 2006, Proceedings of the National Academy of Sciences.

[16]  Yang Shi,et al.  Histone lysine demethylases: emerging roles in development, physiology and disease , 2007, Nature Reviews Genetics.

[17]  F. Forneris,et al.  Structural Basis of LSD1-CoREST Selectivity in Histone H3 Recognition* , 2007, Journal of Biological Chemistry.

[18]  P. Cole,et al.  LSD1 and the chemistry of histone demethylation. , 2007, Current opinion in chemical biology.

[19]  M. Machius,et al.  Structural basis of histone demethylation by LSD1 revealed by suicide inactivation , 2007, Nature Structural &Molecular Biology.

[20]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[21]  F. Forneris,et al.  LSD1: oxidative chemistry for multifaceted functions in chromatin regulation. , 2008, Trends in biochemical sciences.

[22]  M. Nieto,et al.  Evolutionary history of the Snail/Scratch superfamily. , 2009, Trends in genetics : TIG.

[23]  Luyang Sun,et al.  LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer , 2009, Cell.

[24]  R. Versteeg,et al.  Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. , 2009, Cancer research.

[25]  Xueqi Fu,et al.  LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis , 2009, Proceedings of the National Academy of Sciences.

[26]  S. Minucci,et al.  Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer. , 2009, Cancer letters.

[27]  S. Frye,et al.  Epigenetics: tools and technologies. , 2010, Drug discovery today. Technologies.

[28]  B. Zhou,et al.  The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine‐specific demethylase 1 , 2010, The EMBO journal.

[29]  R. Schüle,et al.  Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. , 2010, Carcinogenesis.

[30]  Yang Shi,et al.  Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. , 2010, Annual review of biochemistry.

[31]  J. Mccammon,et al.  Molecular mimicry and ligand recognition in binding and catalysis by the histone demethylase LSD1-CoREST complex. , 2011, Structure.

[32]  B. Ponder,et al.  Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. , 2011, Cancer research.

[33]  Jacob D. Durrant,et al.  POVME: an algorithm for measuring binding-pocket volumes. , 2011, Journal of molecular graphics & modelling.

[34]  A. Mai,et al.  Targeting Histone Demethylases: A New Avenue for the Fight against Cancer. , 2011, Genes & cancer.

[35]  K. Aldape,et al.  Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors. , 2011, Neuro-oncology.

[36]  B. Ponder,et al.  Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers , 2011, International journal of cancer.

[37]  Kristian Helin,et al.  Molecular mechanisms and potential functions of histone demethylases , 2012, Nature Reviews Molecular Cell Biology.

[38]  C. Andrieu-Soler,et al.  A short Gfi-1B isoform controls erythroid differentiation by recruiting the LSD1–CoREST complex through the dimethylation of its SNAG domain , 2012, Journal of Cell Science.

[39]  M. Muers Functional genomics: Complexities of occupancy and sequence , 2012, Nature Reviews Genetics.

[40]  Martin Dugas,et al.  Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia , 2012, Nature Medicine.

[41]  R. Baron,et al.  LSD1/CoREST reversible opening-closing dynamics: discovery of a nanoscale clamp for chromatin and protein binding. , 2012, Biochemistry.